• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性粒细胞白血病或双表型Ph+急性白血病患者的间充质干细胞与白血病克隆无关。

Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone.

作者信息

Wöhrer S, Rabitsch W, Shehata M, Kondo R, Esterbauer H, Streubel B, Sillaber C, Raderer M, Jaeger U, Zielinski C, Valent P

机构信息

Department of Internal Medicine 1, Division of Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria.

出版信息

Anticancer Res. 2007 Nov-Dec;27(6B):3837-41.

PMID:18225540
Abstract

BACKGROUND

Human mesenchymal stem cells (MSCs) are thought to be multipotent cells which primarily reside in the bone marrow. Besides their well-known ability to replicate as undifferentiated cells and to differentiate into diverse lineages of mesenchymal tissues, they were recently suggested to also give rise to haematopoietic and leukaemic/cancer stem cells. In this study, the relationship between MSCs and leukemic stem cells in patients with either chronic myelogenous leukaemia (CML) or the more primitive variant, Ph+ bi-phenotypic leukaemia was investigated.

PATIENTS AND METHODS

Cultured MSCs from 5 patients with CML and 3 patients with bi-phenotypic Ph+ leukaemia, all of them positive for BCP-ABL, were analysed with conventional cytogenetics, fluorescence in situ hybridisation (FISH) and polymerase chain reaction (PCR) for the presence of t(9;22) and BCR-ABL. MSCs were characterised phenotypically with surface markers (+CD73, +CD90, +CD105, -CD34, -CD45) and functionally through their potential to differentiate into both adipocytes and osteoblasts.

RESULTS

MSCs could be cultivated from seven patients. These cells were BCR-ABL negative when analysed with conventional cytogenetics and FISH. Further cytogenetic analysis revealed a normal set of chromosomes without any aberrations. Two patients were BCR-ABL-positive when analysed with PCR, probably as a result of MSC contamination with macrophages.

CONCLUSION

MSCs in patients with CML or Ph+ bi-phenotypic leukaemia are not related to the malignant cell clone.

摘要

背景

人间充质干细胞(MSCs)被认为是多能细胞,主要存在于骨髓中。除了其众所周知的作为未分化细胞进行复制并分化为多种间充质组织谱系的能力外,最近还表明它们也可产生造血干细胞和白血病/癌症干细胞。在本研究中,调查了慢性粒细胞白血病(CML)患者或更原始的变异型Ph+双表型白血病患者中MSCs与白血病干细胞之间的关系。

患者和方法

对5例CML患者和3例双表型Ph+白血病患者培养的MSCs进行分析,所有患者均为BCR-ABL阳性,采用常规细胞遗传学、荧光原位杂交(FISH)和聚合酶链反应(PCR)检测t(9;22)和BCR-ABL的存在情况。通过表面标志物(+CD73、+CD90、+CD105、-CD34、-CD45)对MSCs进行表型鉴定,并通过其分化为脂肪细胞和成骨细胞的潜能进行功能鉴定。

结果

从7例患者中培养出了MSCs。用常规细胞遗传学和FISH分析时,这些细胞BCR-ABL阴性。进一步的细胞遗传学分析显示染色体组正常,无任何畸变。2例患者用PCR分析时BCR-ABL阳性,可能是由于MSCs被巨噬细胞污染所致。

结论

CML或Ph+双表型白血病患者的MSCs与恶性细胞克隆无关。

相似文献

1
Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone.慢性粒细胞白血病或双表型Ph+急性白血病患者的间充质干细胞与白血病克隆无关。
Anticancer Res. 2007 Nov-Dec;27(6B):3837-41.
2
Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.来自慢性髓性白血病t(9;22)患者的骨髓间充质干细胞不含费城染色体,并支持脐血干细胞扩增。
Leuk Res. 2006 Dec;30(12):1493-8. doi: 10.1016/j.leukres.2006.04.013. Epub 2006 Jul 12.
3
Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia.慢性髓性白血病患者骨髓间充质干细胞生物学特性及支持造血功能的评估
Leuk Res. 2006 Aug;30(8):993-1003. doi: 10.1016/j.leukres.2005.12.010. Epub 2006 Jan 31.
4
Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.BCR/ABL基因表达对慢性粒细胞白血病造血细胞不同亚群增殖率的影响。
Br J Haematol. 2006 Oct;135(1):43-51. doi: 10.1111/j.1365-2141.2006.06265.x. Epub 2006 Aug 25.
5
[Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].[培养的人BCR/ABL+ Ph+细胞中调节细胞凋亡的基因的增殖、分化及转录动力学]
Tsitologiia. 2007;49(10):889-900.
6
Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors.苔藓抑素-1对慢性髓性白血病来源的造血祖细胞的影响。
Br J Cancer. 1999 Mar;79(9-10):1406-12. doi: 10.1038/sj.bjc.6690225.
7
Matrix metalloproteinase-9 was involved in the immuno-modulatory defect of mesenchymal stem cell from chronic myeloid leukemia patients.基质金属蛋白酶-9参与慢性髓性白血病患者间充质干细胞免疫调节缺陷。
Chin Med J (Engl). 2011 Aug;124(16):2423-30.
8
Bestatin selectively suppresses the growth of leukemic stem/progenitor cells with BCR/ABL mRNA transcript in patients with chronic myelogeneous leukemia.
Int Immunopharmacol. 2003 Jun;3(6):901-7. doi: 10.1016/S1567-5769(03)00083-3.
9
Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.传统细胞遗传学和荧光原位杂交(FISH)在慢性髓性白血病患者中的诊断作用。
Kathmandu Univ Med J (KUMJ). 2006 Apr-Jun;4(2):171-5.
10
Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.对bcr/abl+慢性髓性白血病患者进行自体非照射树突状细胞疫苗接种。
Br J Haematol. 2007 May;137(4):297-306. doi: 10.1111/j.1365-2141.2007.06547.x. Epub 2007 Apr 4.

引用本文的文献

1
Chromosomal abnormalities of mesenchymal stromal cells in hematological malignancies.血液系统恶性肿瘤中间充质基质细胞的染色体异常。
Oncogene. 2025 Aug 14. doi: 10.1038/s41388-025-03528-4.
2
TNF-α-induced alterations in stromal progenitors enhance leukemic stem cell growth via CXCR2 signaling.肿瘤坏死因子-α诱导的基质祖细胞改变通过CXCR2信号通路增强白血病干细胞生长。
Cell Rep. 2021 Jul 13;36(2):109386. doi: 10.1016/j.celrep.2021.109386.
3
Role of bone marrow adipocytes in leukemia and chemotherapy challenges.骨髓脂肪细胞在白血病和化疗挑战中的作用。
Cell Mol Life Sci. 2019 Jul;76(13):2489-2497. doi: 10.1007/s00018-019-03031-6. Epub 2019 Feb 4.
4
Bone mesenchymal stromal cells exhibit functional inhibition but no chromosomal aberrations in chronic myelogenous leukemia.骨髓间充质基质细胞在慢性粒细胞白血病中表现出功能抑制,但无染色体畸变。
Oncol Lett. 2019 Jan;17(1):999-1007. doi: 10.3892/ol.2018.9681. Epub 2018 Nov 9.
5
K562 chronic myeloid leukemia cells modify osteogenic differentiation and gene expression of bone marrow stromal cells.K562慢性髓性白血病细胞改变骨髓基质细胞的成骨分化和基因表达。
J Cell Commun Signal. 2018 Jun;12(2):441-450. doi: 10.1007/s12079-017-0412-8. Epub 2017 Sep 30.
6
The Bone Marrow Microenvironment in Health and Myeloid Malignancy.骨髓微环境与髓系恶性肿瘤。
Cold Spring Harb Perspect Med. 2018 Jul 2;8(7):a031328. doi: 10.1101/cshperspect.a031328.
7
BCR-ABL1-positive microvesicles malignantly transform human bone marrow mesenchymal stem cells in vitro.BCR-ABL1阳性微泡在体外恶性转化人骨髓间充质干细胞。
Acta Pharmacol Sin. 2017 Nov;38(11):1475-1485. doi: 10.1038/aps.2017.116. Epub 2017 Aug 24.
8
Detection of BCR/ABL Translocation in Bone Marrow Derived Mesenchymal Stem Cells in Egyptian CML Patients.埃及慢性粒细胞白血病患者骨髓来源间充质干细胞中BCR/ABL易位的检测
Open Access Maced J Med Sci. 2015 Jun 15;3(2):231-6. doi: 10.3889/oamjms.2015.040. Epub 2015 Apr 8.
9
CD34(+)/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin.慢性髓性白血病中 CD34(+) / CD38(-) 干细胞表达 Siglec-3(CD33),并对 CD33 靶向药物 gemtuzumab/ozogamicin 有反应。
Haematologica. 2012 Feb;97(2):219-26. doi: 10.3324/haematol.2010.035006. Epub 2011 Oct 11.
10
Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis.异基因 SCT 后,骨髓间充质基质细胞仍然来源于受者,且在骨髓纤维化患者中不携带 JAK2V617F 突变。
Clin Exp Med. 2010 Sep;10(3):205-8. doi: 10.1007/s10238-009-0058-9. Epub 2009 Jul 23.